Literature DB >> 22715189

Drug shortages delay cancer clinical trials.

Merrill Goozner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22715189     DOI: 10.1093/jnci/djs293

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation.

Authors:  Sunil Adige; Rena G Lapidus; Brandon A Carter-Cooper; Alison Duffy; Ciera Patzke; Jennie Y Law; Maria R Baer; Nicholas P Ambulos; Ying Zou; Søren M Bentzen; Ashkan Emadi
Journal:  Cancer Chemother Pharmacol       Date:  2019-04-09       Impact factor: 3.333

2.  Chemotherapy drug shortages in pediatric oncology: a consensus statement.

Authors:  Matthew Decamp; Steven Joffe; Conrad V Fernandez; Ruth R Faden; Yoram Unguru
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

3.  The impact of chemotherapy shortages on COG and local clinical trials: a report from the Children's Oncology Group.

Authors:  Elizabeth G Salazar; M Brooke Bernhardt; Yimei Li; Richard Aplenc; Peter C Adamson
Journal:  Pediatr Blood Cancer       Date:  2015-02-19       Impact factor: 3.167

Review 4.  Development of biosimilars in an era of oncologic drug shortages.

Authors:  Edward Li; Janakiraman Subramanian; Scott Anderson; Dolca Thomas; Jason McKinley; Ira A Jacobs
Journal:  Drug Des Devel Ther       Date:  2015-06-24       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.